Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Belgium
  4. Euronext Bruxelles
  5. Biocartis Group NV
  6. Company
    BCART   BE0974281132

BIOCARTIS GROUP NV

(BCART)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Biocartis Group NV
Biocartis Group NV is a Belgium-based company, which specializes in the development of molecular diagnostic systems, especially for the treatment of cancers and infectious diseases, the products ensure the analysis of biomolecules associated with risk factors, early detection, treatment selection and monitoring of disease. The group has the Idylla system to deliver results within a period of between 35 to 150 minutes.

Number of employees : 484 people.
Sales per Business
2020
Cartridge24.8157.5%
Research & Development Services8.1819%
Idylla System4.3910.2%
Idylla System Rental2.706.3%
License Fees1.814.2%
Idylla System Service1.252.9%
EUR in Million
Sales per region
2020
United States15.6036.2%
Rest of the World11.7727.3%
Great Britain3.979.2%
France3.508.1%
Germany2.956.8%
Spain2.876.6%
China1.994.6%
Belgium0.481.1%
EUR in Million
Managers
Name Title Age Since
Herman Verrelst Chief Executive Officer & Executive Director 47 2017
Jean-Marc Roelandt Chief Financial Officer 55 -
Benoit Devogelaere, Dr. Chief Technology Officer 40 2011
Piet Houwen Chief Operating Officer 52 -
Ann-Christine Sundell Independent Director 56 2018
Luc Gijsens Independent Director 67 2018
Christian Reinaudo, Dr. Independent Chairman 66 2018
Christine D. Kuslich, Dr. Independent Director - -
Renate Degrave Head-Corporate Communications & IR - 2019
Erwin Sablon, Dr. Head-Research & Development, Alliance Management 55 2012
Members of the board
Name Title Age Since
Christian Reinaudo, Dr. Independent Chairman 66 2018
Roald BorrÚ Non-Executive Director 48 2014
Herman Verrelst Chief Executive Officer & Executive Director 47 2017
Ann-Christine Sundell Independent Director 56 2018
Luc Gijsens Independent Director 67 2018
Christine D. Kuslich, Dr. Independent Director - -
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 57,545,663 48,042,200 83.5% 0 0.0% 83.5%
Shareholders
NameEquities%
Invesco Advisers, Inc. 7,026,828 12.2%
Johnson & Johnson Innovation JJDC, Inc. 5,481,128 9.52%
Participatiemaatschappij Vlaanderen NV 2,362,610 4.11%
Credit Suisse Asset Management (Schweiz) AG 2,028,326 3.52%
Debiopharm Innovation Fund /Management/ 1,662,963 2.89%
Mirova SA (Investment Management) 1,073,965 1.87%
Tocqueville Finance SA 844,744 1.47%
Threadneedle Asset Management Ltd. 710,018 1.23%
BNP Paribas Asset Management Belgium SA 340,086 0.59%
AXA Investment Managers (Paris) SA 328,000 0.57%
Markets and indexes
- Compartiment B
- BEL Mid / PEA
Stock Exchange Codes
- Bloomberg Code :  BCART:BE
- Reuters Code :  BCART.BR
- Datastream Code :  
Company contact information
Biocartis Group NV
Generaal De Wittelaan 11B
BE-2800 Mechelen, Antwerpen

Phone : +32 15 632 600
Fax :
web site : https://investors.biocartis.com/en